Boenning & Scattergood’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Boenning & Scattergood’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.68M	Buy	18,657 +8,430	+82%	+$682K	0.27%	99
2022 Q3	$811K	Sell	10,227 -7,030	-41%	-$593K	0.17%	145
2022 Q2	$1.28M	Sell	17,257 -1,400	-8%	-$105K	0.24%	104
2022 Q1	$1.68M	Buy	18,657 +5,357	+40%	+$495K	0.27%	99
2021 Q4	$1.49M	Buy	+13,300	New	+$1.6M	0.24%	105

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Boenning & Scattergood's XBI Position: Q4 2022 in Review

Boenning & Scattergood increased its State Street SPDR S&P Biotech ETF (XBI) stake by 82% in Q4 2022, buying an estimated $682K and bringing the position to 18,657 shares worth $1.68M. The position accounts for 0.27% of the portfolio, ranked #99.

Boenning & Scattergood first reported a position in XBI in Q4 2021 and has held it in 5 quarters since. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

Boenning & Scattergood held 18,657 shares of State Street SPDR S&P Biotech ETF worth $1.68M as of Q4 2022.
Boenning & Scattergood bought 8,430 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $682K.
State Street SPDR S&P Biotech ETF made up 0.27% of Boenning & Scattergood's portfolio in Q4 2022, its #99 holding.
Boenning & Scattergood first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 5 quarters since.
745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.